CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,113
- in 3 filings
Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-10 | Frankenius Equity AB 10% owner | Other acquisition · Series A Convertible Preferred Stock | +205,853 | 435,853 | ||
| 2025-02-05 | Young James Emmett Chief Financial Officer | Purchase | +6,000 | $5.65 | $34K | 30,000 |
| 2025-01-30 | Szela Mary T CEO AND PRESIDENT | Purchase | +5,010 | $5.28 | $26K | 444,259 |
| 2025-01-29 | Gordon Gary B. Director | Grant or award · Director Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-29 | Gordon Gary B. Director | Grant or award · Director Stock Option (right to buy) | +6,250 | 6,250 | ||
| 2025-01-29 | Valle William Director | Grant or award · Director Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-29 | Valle William Director | Grant or award · Director Stock Option (right to buy) | +6,250 | 6,250 | ||
| 2025-01-29 | Szela Mary T CEO AND PRESIDENT | Purchase | +5,030 | $5.03 | $25K | 439,249 |
| 2025-01-28 | Szela Mary T CEO AND PRESIDENT | Purchase | +4,716 | $5.12 | $24K | 434,219 |
| 2025-01-28 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Purchase | +15,000 | $5.17 | $78K | 197,732 |
| 2025-01-27 | Szela Mary T CEO AND PRESIDENT | Grant or award | +40,000 | 424,677 | ||
| 2025-01-27 | Szela Mary T CEO AND PRESIDENT | Purchase | +4,826 | $5.42 | $26K | 429,503 |
| 2025-01-27 | Szela Mary T CEO AND PRESIDENT | Grant or award · Employee Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2025-01-27 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Grant or award | +12,500 | 63,288 | ||
| 2025-01-27 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Purchase | +15,000 | $5.31 | $80K | 182,732 |
| 2025-01-27 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-01-27 | Cox Bryan F. CHIEF OF RESEARCH | Grant or award | +10,625 | 97,007 | ||
| 2025-01-27 | Cox Bryan F. CHIEF OF RESEARCH | Grant or award · Employee Stock Option (right to buy) | +63,750 | 63,750 | ||
| 2025-01-27 | Young James Emmett Chief Financial Officer | Grant or award | +12,500 | 21,726 | ||
| 2025-01-27 | Young James Emmett Chief Financial Officer | Purchase | +24,000 | $5.40 | $130K | 24,000 |
Page 6 of 9 · 161 trades